Seite 1 von 3
Neuester Beitrag: 10.01.21 04:40
|Eröffnet am:||07.02.19 10:01||von: Vassago||Anzahl Beiträge:||67|
|Neuester Beitrag:||10.01.21 04:40||von: Natalesa||Leser gesamt:||6.992|
|Seite: < 1 | 2 | 3 >|
47 Mio. $ Offering
" Kezar Life Sciences, Inc. a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, today announced the pricing of an underwritten public offering of 7,590,909 shares of its common stock, and to certain investors in lieu thereof, pre-funded warrants to purchase 909,091 shares of its common stock at an exercise price of $0.001 per share. The public offering price of each share of common stock is $5.50 and the public offering price of each pre-funded warrant is $5.499 per underlying share. In addition, Kezar has granted the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock. The offering is expected to close on June 11, 2020, subject to customary closing conditions."
Damit hat die Aktie von KZR alle Gewinne wieder abgegeben, die sie durch die letzten News erzielt hatte.